S. Michael Imperiale
Corporate Officer/Principal at PARADIGM BIOPHARMACEUTICALS LIMITED
S. Michael Imperiale active positions
Companies | Position | Start | End |
---|---|---|---|
PARADIGM BIOPHARMACEUTICALS LIMITED | Corporate Officer/Principal | 2020-05-31 | - |
Career history of S. Michael Imperiale
Former positions of S. Michael Imperiale
Companies | Position | Start | End |
---|---|---|---|
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Chief Tech/Sci/R&D Officer | 2007-07-31 | 2008-12-31 |
Nuvelo, Inc. | Chief Tech/Sci/R&D Officer | 2005-12-31 | 2005-12-31 |
EXELIXIS, INC. | Corporate Officer/Principal | 2003-12-31 | 2005-12-31 |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 2003-12-31 | 2003-12-31 |
INTERMUNE INC | Chief Tech/Sci/R&D Officer | 2011-06-16 | - |
BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 2008-12-31 | - |
SCRIPSAMERICA, INC. | Director/Board Member | 2011-03-31 | - |
Independent Dir/Board Member | 2011-03-31 | - |
Training of S. Michael Imperiale
Hahnemann University | Doctorate Degree |
Villanova University | Undergraduate Degree |
Statistics
International
United States | 10 |
Australia | 2 |
Operational
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 1 |
Sectoral
Health Technology | 8 |
Consumer Services | 3 |
Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
SCRIPSAMERICA, INC. | Distribution Services |
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
EXELIXIS, INC. | Health Technology |
PARADIGM BIOPHARMACEUTICALS LIMITED | Health Technology |
Private companies | 4 |
---|---|
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Nuvelo, Inc. | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
- Stock Market
- Insiders
- S. Michael Imperiale
- Experience